These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 24391215)

  • 21. Inhibition of toll-like receptor 7- and 9-mediated alpha/beta interferon production in human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus.
    Schlender J; Hornung V; Finke S; Günthner-Biller M; Marozin S; Brzózka K; Moghim S; Endres S; Hartmann G; Conzelmann KK
    J Virol; 2005 May; 79(9):5507-15. PubMed ID: 15827165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelets Modulate Innate Immune Response Against Human Respiratory Syncytial Virus In Vitro.
    Kullaya VI; de Mast Q; van der Ven A; elMoussaoui H; Kibiki G; Simonetti E; de Jonge MI; Ferwerda G
    Viral Immunol; 2017 Oct; 30(8):576-581. PubMed ID: 28783457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Respiratory syncytial virus differentially activates murine myeloid and plasmacytoid dendritic cells.
    Boogaard I; van Oosten M; van Rijt LS; Muskens F; Kimman TG; Lambrecht BN; Buisman AM
    Immunology; 2007 Sep; 122(1):65-72. PubMed ID: 17472722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Replication-dependent potent IFN-alpha induction in human plasmacytoid dendritic cells by a single-stranded RNA virus.
    Hornung V; Schlender J; Guenthner-Biller M; Rothenfusser S; Endres S; Conzelmann KK; Hartmann G
    J Immunol; 2004 Nov; 173(10):5935-43. PubMed ID: 15528327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of palivizumab for respiratory syncytial virus infection in high-risk children, based on long-term epidemiologic data from Austria.
    Resch B; Sommer C; Nuijten MJ; Seidinger S; Walter E; Schoellbauer V; Mueller WD
    Pediatr Infect Dis J; 2012 Jan; 31(1):e1-8. PubMed ID: 21960187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes.
    Goritzka M; Makris S; Kausar F; Durant LR; Pereira C; Kumagai Y; Culley FJ; Mack M; Akira S; Johansson C
    J Exp Med; 2015 May; 212(5):699-714. PubMed ID: 25897172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response.
    Román M; Calhoun WJ; Hinton KL; Avendaño LF; Simon V; Escobar AM; Gaggero A; Díaz PV
    Am J Respir Crit Care Med; 1997 Jul; 156(1):190-5. PubMed ID: 9230746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Correlation between the numbers of peripheral blood dendritic cells and the clinical manifestations in children with respiratory syncytial virus bronchiolitis].
    Zhang J; Weng K; Mei X; Zhang B; Zheng Y; Ke Z; Wu A
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jul; 29(7):748-50. PubMed ID: 23837988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG). Respiratory Syncytial Virus Immune Globulin Study Group.
    Groothuis JR; Simoes EA; Hemming VG
    Pediatrics; 1995 Apr; 95(4):463-7. PubMed ID: 7700741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low neonatal Toll-like receptor 4-mediated interleukin-10 production is associated with subsequent atopic dermatitis.
    Belderbos ME; Knol EF; Houben ML; van Bleek GM; Wilbrink B; Kimpen JL; Rovers M; Bont L
    Clin Exp Allergy; 2012 Jan; 42(1):66-75. PubMed ID: 22092594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human genetics and respiratory syncytial virus disease: current findings and future approaches.
    Choi EH; Lee HJ; Chanock SJ
    Curr Top Microbiol Immunol; 2013; 372():121-37. PubMed ID: 24362687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survey of pediatric ward hospitalization due to respiratory syncytial virus infection after the introduction of palivizumab to high-risk infants in Japan.
    Kusuda S; Takahashi N; Saitoh T; Terai M; Kaneda H; Kato Y; Ohashi A; Watabe S; Joh-o K; Hirai K
    Pediatr Int; 2011 Jun; 53(3):368-73. PubMed ID: 20854284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of Immunological Maturity on Respiratory Syncytial Virus-Induced Morbidity in Young Children.
    Verhoeven D
    Viral Immunol; 2019 Mar; 32(2):76-83. PubMed ID: 30499759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RSV respiratory infection in children under 5 y.o.--dynamics of the immune response Th1/Th2 and IgE.
    Gut W; Pancer K; Abramczuk E; Cześcik A; Dunal-Szczepaniak M; Lipka B; Litwińska B
    Przegl Epidemiol; 2013; 67(1):17-22, 105-9. PubMed ID: 23745370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced interferon-gamma expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease.
    Aberle JH; Aberle SW; Dworzak MN; Mandl CW; Rebhandl W; Vollnhofer G; Kundi M; Popow-Kraupp T
    Am J Respir Crit Care Med; 1999 Oct; 160(4):1263-8. PubMed ID: 10508817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BRD4 Couples NF-κB/RelA with Airway Inflammation and the IRF-RIG-I Amplification Loop in Respiratory Syncytial Virus Infection.
    Tian B; Yang J; Zhao Y; Ivanciuc T; Sun H; Garofalo RP; Brasier AR
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Respiratory syncytial virus G protein CX3C motif impairs human airway epithelial and immune cell responses.
    Chirkova T; Boyoglu-Barnum S; Gaston KA; Malik FM; Trau SP; Oomens AG; Anderson LJ
    J Virol; 2013 Dec; 87(24):13466-79. PubMed ID: 24089561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delivery of cytokines by recombinant virus in early life alters the immune response to adult lung infection.
    Harker JA; Lee DC; Yamaguchi Y; Wang B; Bukreyev A; Collins PL; Tregoning JS; Openshaw PJ
    J Virol; 2010 May; 84(10):5294-302. PubMed ID: 20200251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flt3 ligand improves the innate response to respiratory syncytial virus and limits lung disease upon RSV reexposure in neonate mice.
    Remot A; Descamps D; Jouneau L; Laubreton D; Dubuquoy C; Bouet S; Lecardonnel J; Rebours E; Petit-Camurdan A; Riffault S
    Eur J Immunol; 2016 Apr; 46(4):874-84. PubMed ID: 26681580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Respiratory syncytial virus induces indoleamine 2,3-dioxygenase activity: a potential novel role in the development of allergic disease.
    Ajamian F; Wu Y; Ebeling C; Ilarraza R; Odemuyiwa SO; Moqbel R; Adamko DJ
    Clin Exp Allergy; 2015 Mar; 45(3):644-59. PubMed ID: 25627660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.